The FDA accepted a resubmitted new drug application for reproxalap, a first-in-class investigational topical therapy for dry ...

Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical firm pioneering therapies delivered through the suprachoroidal ...

Joint Venture Partner Presents AI Technology at Roche Ophthalmology Conference – Avant Technologies, Inc. (“Avant” or the“Company”), an emerging technology company developing healthcare solutions ...

Joint Venture Partner Presents AI Technology at Roche Ophthalmology Conference - Avant Technologies, Inc. ("Avant" or the "Company"), an emerging technology company developing healthcare solutions ...

As Dry Eye Awareness Month kicks off, Bausch + Lomb is rolling out a new campaign to improve education about the condition.

The campaign aims to educate about dry eye through personal stories, compelling imagery and new survey data, and encourages people with symptoms to speak with their eye doctor to find relief.

VAUGHAN, Ontario, July 01, 2025--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today launched "Eyes Tell ...

New survey data reinforces the importance of ongoing awareness and education to help dry eye sufferers seek relief sooner Eyes Tell the Story campaign aims to close the awareness gap through ...

The campaign aims to educate about dry eye through personal stories, compelling imagery and new survey data, and encourages people with symptoms to speak with their eye doctor to find relief.

For others, relief may be found through over-the-counter eye drops for occasional needs or daily use of supplements for dry eyes to help from the inside out.

VAUGHAN, Ontario, June 26, 2025--Bausch + Lomb Corporation (NYSE/TSX: BLCO) ("Bausch + Lomb" or the "company"), a leading global eye health company dedicated to helping people see better to live ...